{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:17:37Z","timestamp":1795112257349,"version":"4.10.3"},"reference-count":206,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","surveyophthalmol.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.survophthal.2024.08.003","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T21:10:15Z","timestamp":1725138615000},"page":"653-675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Macular neovascularization"],"prefix":"10.1016","volume":"70","author":[{"given":"Jay U.","family":"Sheth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giridhar","family":"Anantharaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Y.Y.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Chakravarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taraprasad","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2024.08.003_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/aje\/kws004","article-title":"20\/20--Alcohol and age-related macular degeneration: the Melbourne Collaborative Cohort Study","volume":"176","author":"Adams","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.survophthal.2014.10.002","article-title":"The other CNVM: a review of myopic choroidal neovascularization treatment in the age of anti-vascular endothelial growth factor agents","volume":"60","author":"Adatia","year":"2015","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12348-018-0155-6","article-title":"An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management","volume":"8","author":"Agarwal","year":"2018","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.survophthal.2024.08.003_bib4","first-page":"2224","article-title":"Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: age-related eye disease study report number 3","volume":"107","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib5","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.2013.4997","article-title":"Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial","volume":"309","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.survophthal.2024.08.003_bib6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/IAE.0000000000001628","article-title":"Biomarkers of neovascular activity in age-related macular degeneration using optical coherence tomography angiography","volume":"38","author":"Al-Sheikh","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.08.003_bib7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00417-013-2525-y","article-title":"Characterisation of reticular pseudodrusen and their central target aspect in multi-spectral, confocal scanning laser ophthalmoscopy","volume":"252","author":"Alten","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib8","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4103\/ijo.IJO_1136_17","article-title":"Polypoidal choroidal vasculopathy: pearls in diagnosis and management","volume":"66","author":"Anantharaman","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib9","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.ophtha.2012.05.027","article-title":"The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1)","volume":"119","author":"Chew","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40942-021-00325-5","article-title":"Pipeline therapies for neovascular age related macular degeneration","volume":"7","author":"Arepalli","year":"2021","journal-title":"Int J Retin Vitr"},{"key":"10.1016\/j.survophthal.2024.08.003_bib11","doi-asserted-by":"crossref","unstructured":"Argon laser photocoagulation for neovascular maculopathy. Three-year results from randomized clinical trials. Macular Photocoagulation Study Group. Arch Ophthalmol. 1986;104:694\u2013701.","DOI":"10.1001\/archopht.1986.01050170084028"},{"key":"10.1016\/j.survophthal.2024.08.003_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/IAE.0000000000001617","article-title":"Optical coherence tomography angiography to distinguish choroidal neovascularization from macular inflammatory lesions in multifocal choroiditis","volume":"38","author":"Astroz","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.08.003_bib13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000310695","article-title":"Evaluation of choroidal neovascularization in age-related macular degeneration with fluorescein and indocyanine green videoangiography","volume":"210","author":"Atmaca","year":"1996","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.survophthal.2024.08.003_bib14","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ajo.2013.04.040","article-title":"Risk of choroidal neovascularization among the uveitides","volume":"156","author":"Baxter","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib15","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/bjophthalmol-2014-305643","article-title":"MultiColor imaging in the evaluation of geographic atrophy due to age-related macular degeneration","volume":"99","author":"Ben Moussa","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.mam.2012.04.005","article-title":"Understanding age-related macular degeneration (AMD): relationships between the photoreceptor\/retinal pigment epithelium\/Bruch's membrane\/choriocapillaris complex","volume":"33","author":"Bhutto","year":"2012","journal-title":"Mol Asp Med"},{"key":"10.1016\/j.survophthal.2024.08.003_bib17","first-page":"198","volume":"119","author":"Bressler","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib18","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/bjophthalmol-2021-319637","article-title":"Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes","volume":"107","author":"Bressler","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ophtha.2008.10.018","article-title":"Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study","volume":"116","author":"Brown","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib20","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0140-6736(23)02577-1","article-title":"Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2\/3 trial","volume":"403","author":"Brown","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2024.08.003_bib21","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0161-6420(96)30561-7","article-title":"Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome","volume":"103","author":"Brown","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10384-007-0498-2","article-title":"Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients","volume":"52","author":"Byeon","year":"2008","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib23","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ophtha.2010.09.026","article-title":"Relationship of smoking and cardiovascular risk factors with polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese persons","volume":"118","author":"Cackett","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib24","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1136\/bjophthalmol-2014-306226","article-title":"Significance of the hyperautofluorescent ring associated with choroidal neovascularisation in eyes undergoing anti-VEGF therapy for wet age-related macular degeneration","volume":"99","author":"Camacho","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9982883","article-title":"Inflammatory choroidal neovascular membranes: clinical profile, treatment effectiveness, and visual prognosis","volume":"2021","author":"Carrola","year":"2021","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/1120672118785495","article-title":"Optical coherence tomography angiography in myopic choroidal neovascularization after intravitreal ranibizumab","volume":"29","author":"Cennamo","year":"2019","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12916-015-0329-0","article-title":"Thyroid function and age-related macular degeneration: a prospective population-based cohort study--the Rotterdam Study","volume":"13","author":"Chaker","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.survophthal.2024.08.003_bib28","article-title":"Off-label intravitreal brolucizumab for recalcitrant diabetic macular edema: a real-world case series","volume":"24","author":"Chakraborty","year":"2021","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.survophthal.2024.08.003_bib29","article-title":"Role of intravitreal brolucizumab with intravitreal rtPA and pneumatic displacement for submacular hemorrhage: a case series","volume":"25","author":"Chakraborty","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.survophthal.2024.08.003_bib30","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/IAE.0000000000001702","article-title":"Polypoidal choroidal vasculopathy upon optical coherence tomographic angiography","volume":"38","author":"Chan","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.08.003_bib31","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1136\/bjo.2005.074716","article-title":"Choroidal neovascularisation in pathological myopia: an update in management","volume":"89","author":"Chan","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib32","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3928\/15428877-20091030-07","article-title":"Polypoidal choroidal vasculopathy in Taiwanese patients","volume":"40","author":"Chang","year":"2009","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.survophthal.2024.08.003_bib33","first-page":"816","article-title":"Genetic associations in polypoidal choroidal vasculopathy: a systematic review and meta-analysis","volume":"18","author":"Chen","year":"2012","journal-title":"Mol Vis"},{"key":"10.1016\/j.survophthal.2024.08.003_bib34","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1097\/IAE.0000000000002292","article-title":"Ranibizumab versus verteporfin photodynamic therapy in asian patients with myopic choroidal neovascularization: brilliance, a 12-month, randomized, double-masked study","volume":"39","author":"Chen","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.08.003_bib35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ajo.2016.06.029","article-title":"Spectral-domain optical coherence tomography angiography findings in multifocal choroiditis with active lesions","volume":"169","author":"Cheng","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib36","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","article-title":"Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management","volume":"125","author":"Cheung","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib37","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ophtha.2020.08.006","article-title":"Polypoidal choroidal vasculopathy: consensus nomenclature and non-indocyanine green angiograph diagnostic criteria from the asia-pacific ocular imaging society PCV workgroup","volume":"128","author":"Cheung","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib38","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jamaophthalmol.2022.1640","article-title":"AREDS2 Research Group. long-term outcomes of adding lutein\/zeaxanthin and \u03c9-3 fatty acids to the AREDS supplements on age-related macular degeneration progression: AREDS2 report 28","volume":"140","author":"Chew","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/IAE.0000000000003294","article-title":"Step-wise approach to the management of submacular hemorrhage using pneumatic displacement and vitrectomy: the manchester protocol","volume":"42","author":"Chew","year":"2022","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.08.003_bib40","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/ajcn\/86.4.1210","article-title":"Dietary carbohydrate and the progression of age-related macular degeneration: a prospective study from the Age-Related Eye Disease Study","volume":"86","author":"Chiu","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.survophthal.2024.08.003_bib41","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0002-9440(10)62248-1","article-title":"Decreased thickness and integrity of the macular elastic layer of Bruch's membrane correspond to the distribution of lesions associated with age-related macular degeneration","volume":"166","author":"Chong","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib42","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jcjo.2016.02.012","article-title":"Hypertension as a risk factor for recurrent subretinal hemorrhage in polypoidal choroidal vasculopathy","volume":"51","author":"Chung","year":"2016","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib43","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0161-6420(96)30515-0","article-title":"Etiology of choroidal neovascularization in young patients","volume":"103","author":"Cohen","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ajo.2010.02.019","article-title":"Retinal pseudocysts in age-related geographic atrophy","volume":"150","author":"Cohen","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib45","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.ophtha.2017.05.035","article-title":"EYE-RISK consortium; European Eye Epidemiology (E3) consortium. Prevalence of Age-Related Macular Degeneration in Europe: The Past and the Future","volume":"124","author":"Colijn","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib46","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ophtha.2012.03.053","article-title":"Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results","volume":"119","author":"Martin","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib47","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1097\/IAE.0000000000000766","article-title":"Optical coherence tomography angiography versus traditional multimodal imaging in assessing the activity of exudative age-related macular degeneration: a new diagnostic challenge","volume":"35","author":"Coscas","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.08.003_bib48","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.ajo.2015.08.028","article-title":"Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease","volume":"160","author":"Dansingani","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib49","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/IAE.0000000000000742","article-title":"En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography","volume":"36","author":"Dansingani","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.08.003_bib50","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ophtha.2017.08.030","article-title":"Natural history of subclinical neovascularization in nonexudative age-related macular degeneration using swept-source OCT angiography","volume":"125","author":"de Oliveira Dias","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib51","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.gendis.2021.02.009","article-title":"Age-related macular degeneration: epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy","volume":"9","author":"Deng","year":"2021","journal-title":"Genes Dis"},{"key":"10.1016\/j.survophthal.2024.08.003_bib52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ophtha.2020.06.028","article-title":"Hawk and harrier: ninety-six-week outcomes from the phase 3 trials of brolucizumab for neovascular age-related macular degeneration","volume":"128","author":"Dugel","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib53","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/IAE.0000000000001710","article-title":"Inflammatory choroidal neovascular membrane: long-term visual and anatomical outcomes after intravitreal anti-vascular endothelial growth factor therapy","volume":"38","author":"D\u02bcsouza","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.08.003_bib54","first-page":"CD006928","article-title":"Macular translocation for neovascular age-related macular degeneration","volume":"4","author":"Eandi","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.survophthal.2024.08.003_bib55","first-page":"1215","article-title":"The results of the 10 year follow-on study of the age-related eye disease study 2 (AREDS2)","volume":"62","author":"Chew","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2024.08.003_bib56","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/IAE.0b013e3181e7976b","article-title":"Do we need a new classification for choroidal neovascularization in age-related macular degeneration?","volume":"30","author":"Freund","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.08.003_bib57","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0002-9394(00)00769-8","article-title":"Initial experience of inferior limited macular translocation for subfoveal choroidal neovascularization resulting from causes other than age-related macular degeneration","volume":"131","author":"Fujii","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib58","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0002-9394(00)00770-4","article-title":"Visual function after foveal translocation with 360-degree retinotomy and simultaneous torsional muscle surgery in patients with myopic neovascular maculopathy","volume":"131","author":"Fujikado","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib59","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4103\/0301-4738.159868","article-title":"Fundus autofluorescence applications in retinal imaging","volume":"63","author":"Gabai","year":"2015","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib60","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1167\/iovs.10-6312","article-title":"Optical coherence tomography: history, current status, and laboratory work","volume":"52","author":"Gabriele","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2024.08.003_bib61","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/archopht.1967.00980030457009","article-title":"A combined technique of fluorescein funduscopy and angiography of the eye","volume":"78","author":"Gass","year":"1967","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib62","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.3390\/ijerph17176378","article-title":"Patient-perceived benefit of treatment in polypoidal choroidal vasculopathy: a pilot study","volume":"17","author":"Ghoshal","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.survophthal.2024.08.003_bib63","first-page":"CD006931","article-title":"Submacular surgery for choroidal neovascularisation secondary to age-related macular degeneration","volume":"2","author":"Giansanti","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.survophthal.2024.08.003_bib64","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1167\/iovs.16-19735","article-title":"Thyroid dysfunction and ten-year incidence of age-related macular degeneration","volume":"57","author":"Gopinath","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2024.08.003_bib65","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40942-020-00228-x","article-title":"Surgical management of submacular hemorrhage due to n-AMD: a comparison of three surgical methods","volume":"6","author":"Grohmann","year":"2020","journal-title":"Int J Retin Vitr"},{"key":"10.1016\/j.survophthal.2024.08.003_bib66","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ajo.2003.09.042","article-title":"Choroidal neovascularization","volume":"137","author":"Grossniklaus","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib67","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/archopht.116.2.150","article-title":"Effect of aging on foveolar choroidal circulation","volume":"116","author":"Grunwald","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib68","first-page":"385","article-title":"Foveolar choroidal blood flow in age-related macular degeneration","volume":"39","author":"Grunwald","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2024.08.003_bib69","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.1110359","article-title":"Complement factor H variant increases the risk of age-related macular degeneration","volume":"308","author":"Haines","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.survophthal.2024.08.003_bib70","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0021-5155(99)00094-5","article-title":"Confocal scanning laser microscopic findings of excised choroidal neovascular membranes of age-related macular degeneration and their comparison with the clinical features","volume":"43","author":"Hashimoto","year":"1999","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib71","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/opo.12675","article-title":"Risk factors for progression of age-related macular degeneration","volume":"40","author":"Heesterbeek","year":"2020","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.survophthal.2024.08.003_bib72","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"View 1 and view 2 Study Groups. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib73","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(22)00010-1","article-title":"Tenaya and Lucerne investigators. efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials","volume":"399","author":"Heier","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2024.08.003_bib74","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.2174\/1381612825666190206105943","article-title":"Pharmacotherapy for choroidal neovascularization due to uncommon causes","volume":"24","author":"Ho","year":"2018","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.survophthal.2024.08.003_bib75","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ophtha.2021.04.031","article-title":"COLUMBUS-AMD study group. Efficacy and safety of biosimilar FYB201 compared with ranibizumab in neovascular age-related macular degeneration","volume":"129","author":"Holz","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib76","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000355488","article-title":"Polypoidal choroidal vasculopathy: clinical features and genetic predisposition","volume":"231","author":"Honda","year":"2014","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.survophthal.2024.08.003_bib77","unstructured":"Hutton D. Outlook Therapeutics re-submits BLA for ONS-5010. \u3008https:\/\/www.ophthalmologytimes.com\/view\/outlook-therapeutics-re-submits-bla-for-ons-5010\u3009. Accessed on March 15th, 2024."},{"key":"10.1016\/j.survophthal.2024.08.003_bib78","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.ophtha.2015.01.025","article-title":"MYRROR Investigators. Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization: the MYRROR Study","volume":"122","author":"Ikuno","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib79","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1097\/IAE.0000000000000777","article-title":"Optical coherence tomography angiography of polypoidal choroidal vasculopathy and polypoidal choroidal neovascularization","volume":"35","author":"Inoue","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.08.003_bib80","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ophtha.2012.04.015","article-title":"Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial","volume":"119","author":"IVAN Study Investigators","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib81","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1167\/iovs.02-1192","article-title":"Nutritional manipulation of primate retinas, III: effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys","volume":"46","author":"Johnson","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2024.08.003_bib82","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.ophtha.2014.03.013","article-title":"Five-year incidence, progression, and risk factors for age-related macular degeneration: the age, gene\/environment susceptibility study","volume":"121","author":"Jonasson","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib83","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s40123-020-00291-5","article-title":"Retinal pigment epithelial detachment in age-related macular degeneration","volume":"9","author":"Karampelas","year":"2020","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.survophthal.2024.08.003_bib84","first-page":"118","article-title":"Inflammatory choroidal neovascular membranes in patients with noninfectious uveitis: the place of intravitreal Anti-VEGF therapy","volume":"9","author":"Karti","year":"2020","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib85","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1167\/iovs.05-1430","article-title":"Analysis of CFH, TLR4, and APOE polymorphism in India suggests the Tyr402His variant of CFH to be a global marker for age-related macular degeneration","volume":"47","author":"Kaur","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2024.08.003_bib86","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.ophtha.2009.10.007","article-title":"The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis","volume":"117","author":"Kawasaki","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100865","article-title":"Central serous chorioretinopathy: an update on risk factors, pathophysiology and imaging modalities","volume":"79","author":"Kaye","year":"2020","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.survophthal.2024.08.003_bib88","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1679197","article-title":"Immune privilege and eye-derived T-regulatory cells","volume":"2018","author":"Keino","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.survophthal.2024.08.003_bib89","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/IAE.0b013e31823beb14","article-title":"Polypoidal choroidal vasculopathy: simultaneous indocyanine green angiography and eye-tracked spectral domain optical coherence tomography findings","volume":"32","author":"Khan","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.08.003_bib90","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/jamaophthalmol.2020.2699","article-title":"Efficacy of every four monthly and quarterly dosing of faricimab vs ranibizumab in neovascular age-related macular degeneration: the stairway phase 2 randomized clinical trial","volume":"138","author":"Khanani","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib91","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/aje\/kwf092","article-title":"Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study","volume":"156","author":"Klein","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib92","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0161-6420(03)00599-2","article-title":"The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study","volume":"110","author":"Klein","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib93","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.survophthal.2024.08.003_bib94","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1136\/bjo.2006.103796","article-title":"Physical activity and the 15-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study","volume":"90","author":"Knudtson","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib95","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ajo.2007.01.036","article-title":"Alcohol consumption and the 15-year cumulative incidence of age-related macular degeneration","volume":"143","author":"Knudtson","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib96","first-page":"59","article-title":"Importance of M\u00fcller Cells","volume":"5","author":"Kobat","year":"2020","journal-title":"Beyoglu Eye J"},{"key":"10.1016\/j.survophthal.2024.08.003_bib97","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.ophtha.2013.06.020","article-title":"GEFAL study group. ranibizumab versus bevacizumab for neovascular age-related macular degeneration: results from the GEFAL noninferiority randomized trial","volume":"120","author":"Kodjikian","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib98","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/bjophthalmol-2012-302391","article-title":"MANTA Research Group. A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration","volume":"97","author":"Krebs","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib99","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.eye.6700706","article-title":"Polypoidal choroidal vasculopathy and exudative age-related macular degeneration in Greek population","volume":"18","author":"Ladas","year":"2004","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2024.08.003_bib100","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s004170000180","article-title":"Polypoidal choroidal vasculopathy in Caucasians","volume":"238","author":"Lafaut","year":"2000","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib101","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1097\/IAE.0000000000001744","article-title":"Efficacy and safety of ranibizumab for the treatment of choroidal neovascularization due to uncommon cause: twelve-month results of the MINERVA study","volume":"38","author":"Lai","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.08.003_bib102","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.3390\/jcm11185340","article-title":"Association of fundus autofluorescence abnormalities and pachydrusen in central serous chorioretinopathy and polypoidal choroidal vasculopathy","volume":"11","author":"Lai","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.survophthal.2024.08.003_bib103","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(24)00063-1","article-title":"Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial","volume":"403","author":"Lanzetta","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2024.08.003_bib104","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.preteyeres.2009.10.001","article-title":"Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease?","volume":"29","author":"Laude","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.survophthal.2024.08.003_bib105","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1167\/iovs.12-9538","article-title":"Genetic factors for choroidal neovascularization associated with high myopia","volume":"53","author":"Leveziel","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2024.08.003_bib106","article-title":"Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration","volume":"5","author":"Li","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.survophthal.2024.08.003_bib107","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.ophtha.2014.03.026","article-title":"AURORA Study Group. Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA study","volume":"121","author":"Li","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib108","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jamaophthalmol.2020.2443","article-title":"EVEREST II Study Group. Comparison of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: the EVEREST II randomized clinical trial","volume":"138","author":"Lim","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib109","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3390\/ijerph15050902","article-title":"Evidence for an association between macular degeneration and thyroid cancer in the aged population","volume":"15","author":"Lin","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.survophthal.2024.08.003_bib110","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1177\/1120672120927256","article-title":"The pattern and gender disparity in global burden of age-related macular degeneration","volume":"31","author":"Lin","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib111","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.ophtha.2010.01.020","article-title":"Prevalence and progression of myopic retinopathy in Chinese adults: the Beijing Eye Study","volume":"117","author":"Liu","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib112","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ajo.2018.08.026","article-title":"PHOENIX Study Group. Conbercept for treatment of neovascular age-related macular degeneration: results of the randomized phase 3 PHOENIX study","volume":"197","author":"Liu","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib113","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00417-007-0575-8","article-title":"Subtype lesions of neovascular age-related macular degeneration in Chinese patients","volume":"245","author":"Liu","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib114","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/APO.0000000000000354","article-title":"Role of ocular imaging in diagnosis and determining response to therapeutic interventions in posterior and panuveitis","volume":"10","author":"Mahendradas","year":"2021","journal-title":"Asia Pac J Ophthalmol (Philos)"},{"key":"10.1016\/j.survophthal.2024.08.003_bib115","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1167\/iovs.09-3610","article-title":"Correlation of high-definition optical coherence tomography and fluorescein angiography imaging in neovascular macular degeneration","volume":"50","author":"Malamos","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2024.08.003_bib116","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/archopht.116.2.227","article-title":"Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons","volume":"116","author":"Mangione","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib117","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajo.2007.03.047","article-title":"Clinical characteristics of exudative age-related macular degeneration in Japanese patients","volume":"144","author":"Maruko","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib118","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00417-009-1276-2","article-title":"Combined cases of polypoidal choroidal vasculopathy and typical age-related macular degeneration","volume":"248","author":"Maruko","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib119","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/bjo.2006.095109","article-title":"Fundus autofluorescence in exudative age-related macular degeneration","volume":"91","author":"McBain","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib120","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/bjophthalmol-2015-307663","article-title":"Past physical activity and age-related macular degeneration: the Melbourne Collaborative Cohort Study","volume":"100","author":"McGuinness","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib121","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248760","article-title":"Photodynamic therapy combined with anti-vascular endothelial growth factor therapy for pachychoroid neovasculopathy","volume":"16","author":"Miki","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.survophthal.2024.08.003_bib122","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/IAE.0000000000002556","article-title":"Spatial distribution of choriocapillaris impairment in eyes with choroidal neovascularization secondary to age-related macular degeneration: a quantitative OCT angiography study","volume":"40","author":"Moult","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.08.003_bib123","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/IAE.0b013e3182993f66","article-title":"Multimodal imaging of pigment epithelial detachment: a guide to evaluation","volume":"33","author":"Mrejen","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.08.003_bib124","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1471-2415-14-159","article-title":"A hyporeflective space between hyperreflective materials in pigment epithelial detachment and Bruch's membrane in neovascular age-related macular degeneration","volume":"14","author":"Mukai","year":"2014","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib125","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/IAE.0000000000000488","article-title":"Type 3 neovascularization: evolution, association with pigment epithelial detachment, and treatment response as revealed by spectral domain optical coherence tomography","volume":"35","author":"Nagiel","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.08.003_bib126","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/jcp.22708","article-title":"Regulation of VEGF expression in human retinal cells by cytokines: implications for the role of inflammation in age-related macular degeneration","volume":"227","author":"Nagineni","year":"2012","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib127","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3928\/23258160-20210429-01","article-title":"Biosimilars for the treatment of retinal diseases","volume":"52","author":"Narayanan","year":"2021","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"key":"10.1016\/j.survophthal.2024.08.003_bib128","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.preteyeres.2013.09.003","article-title":"Photodynamic therapy for polypoidal choroidal vasculopathy","volume":"37","author":"Nowak-Sliwinska","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.survophthal.2024.08.003_bib129","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1136\/bjophthalmol-2021-319090","article-title":"Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK","volume":"106","author":"Ogura","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.preteyeres.2017.10.005","article-title":"Diagnosis and treatment guideline for myopic choroidal neovascularization due to pathologic myopia","volume":"63","author":"Ohno-Matsui","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.survophthal.2024.08.003_bib131","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ajo.2018.05.026","article-title":"The treat-and-extend injection regimen versus alternate dosing strategies in age-related macular degeneration: a systematic review and meta-analysis","volume":"192","author":"Okada","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib132","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ophtha.2003.05.030","article-title":"Fluorescein angiographic lesion type frequency in neovascular age-related macular degeneration","volume":"111","author":"Olsen","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib133","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/tjo.tjo_35_18","article-title":"Polypoidal choroidal vasculopathy: an update on current management and review of literature","volume":"9","author":"Palkar","year":"2019","journal-title":"Taiwan J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100456","article-title":"Binding of Gtf2i-\u03b2\/\u03b4 transcription factors to the ARMS2 gene leads to increased circulating HTRA1 in AMD patients and in vitro","volume":"296","author":"Pan","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.survophthal.2024.08.003_bib135","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1001\/archophthalmol.2009.130","article-title":"CAREDS Research Study Group. Association between dietary fat intake and age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS): an ancillary study of the Women's Health Initiative","volume":"127","author":"Parekh","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib136","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/546786","article-title":"Mechanism of inflammation in age-related macular degeneration","volume":"2012","author":"Parmeggiani","year":"2012","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.survophthal.2024.08.003_bib137","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3390\/ijms22031170","article-title":"Neovascular macular degeneration: a review of etiology, risk factors, and recent advances in research and therapy","volume":"22","author":"Pugazhendhi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.survophthal.2024.08.003_bib138","doi-asserted-by":"crossref","unstructured":"Radke N.V., Mohamed S., Brown R.B., et al. Review on the Safety and Efficacy of Brolucizumab for Neovascular Age-Related Macular Degeneration From Major Studies and Real-World Data [published correction appears in Asia Pac J Ophthalmol (Phila). 2023 Jul-Aug 01;12(4):422. Amin, Hivam V [corrected to Amin, Shivam V]]. Asia Pac J Ophthalmol (Phila). 2023;12:168\u2013183.","DOI":"10.1097\/APO.0000000000000629"},{"key":"10.1016\/j.survophthal.2024.08.003_bib139","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ophtha.2009.08.030","article-title":"Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease","volume":"117","author":"Rao","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib140","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.oret.2021.12.007","article-title":"Impact of intra- and subretinal fluid on vision based on volume quantification in the HARBOR trial","volume":"6","author":"Riedl","year":"2022","journal-title":"Ophthalmol Retin"},{"key":"10.1016\/j.survophthal.2024.08.003_bib141","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.ophtha.2020.04.019","article-title":"Asian Eye Epidemiology Consortium. Prevalence and pattern of geographic atrophy in Asia: the asian eye epidemiology consortium","volume":"127","author":"Rim","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib142","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/j.ophtha.2013.03.046","article-title":"SEVEN-UP Study Group. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP)","volume":"120","author":"Rofagha","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib143","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2024.08.003_bib144","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4103\/ijo.IJO_262_16","article-title":"Inflammatory choroidal neovascularization in Indian eyes: Etiology, clinical features, and outcomes to anti-vascular endothelial growth factor","volume":"65","author":"Roy","year":"2017","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib145","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ophtha.2011.09.027","article-title":"Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis","volume":"119","author":"Rudnicka","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib146","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bjo.85.9.1041","article-title":"Surgical removal of subfoveal choroidal neovascularisation in highly myopic patients","volume":"85","author":"Ruiz-Moreno","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib147","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243458","article-title":"Fundus autofluorescence of retinal angiomatous proliferation","volume":"15","author":"Saito","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.survophthal.2024.08.003_bib148","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/IAE.0b013e31826ffe9d","article-title":"Systemic risk factors associated with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration","volume":"33","author":"Sakurada","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.08.003_bib149","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.drudis.2022.04.013","article-title":"Novel and investigational therapies for wet and dry age-related macular degeneration","volume":"27","author":"Sarkar","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.survophthal.2024.08.003_bib150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00006982-200104000-00004","article-title":"Polypoidal choroidal vasculopathy in Italy","volume":"21","author":"Scassellati-Sforzolini","year":"2001","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.08.003_bib151","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1097\/IAE.0000000000000471","article-title":"Outer retinal tubulation in advanced age-related macular degeneration: optical coherence tomographic findings correspond to histology","volume":"35","author":"Schaal","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.08.003_bib152","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ophtha.2010.09.004","article-title":"EXCITE Study Group. Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study","volume":"118","author":"Schmidt-Erfurth","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib153","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/ICU.0000000000000469","article-title":"Optical coherence tomography angiography in the management of age-related macular degeneration","volume":"29","author":"Schneider","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib154","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/archopht.121.6.785","article-title":"Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio","volume":"121","author":"Seddon","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib155","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/archopht.123.6.774","article-title":"Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers","volume":"123","author":"Seddon","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib156","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1167\/iovs.14-15841","article-title":"Risk Prediction for Progression of Macular Degeneration: 10 common and rare genetic variants, demographic, environmental, and macular covariates","volume":"56","author":"Seddon","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2024.08.003_bib157","first-page":"368","article-title":"Real life clinical effectiveness of Razumab\u00ae (World's First Biosimilar Ranibizumab) in wet age-related macular degeneration: a subgroup analysis of pooled retrospective RE-ENACT study","volume":"6","author":"Sharma","year":"2018","journal-title":"Int J Ophthalmol Eye"},{"key":"10.1016\/j.survophthal.2024.08.003_bib158","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000488602","article-title":"Real-life clinical effectiveness of Razumab\u00ae (the World's First Biosimilar of Ranibizumab) in retinal vein occlusion: a subgroup analysis of the pooled retrospective RE-ENACT Study","volume":"241","author":"Sharma","year":"2019","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.survophthal.2024.08.003_bib159","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s40123-019-00228-7","article-title":"RE-ENACT 2 Study Investigators Group. A multicenter, retrospective study (RE-ENACT 2) on the use of Razumab\u2122 (World's first biosimilar ranibizumab) in wet age-related macular degeneration","volume":"9","author":"Sharma","year":"2020","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.survophthal.2024.08.003_bib160","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40123-020-00277-3","article-title":"A multicenter, retrospective study (RE-ENACT 2) on Razumab\u2122 (World's first biosimilar ranibizumab) in retinal vein occlusion","volume":"9","author":"Sharma","year":"2020","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.survophthal.2024.08.003_bib161","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.4103\/ijo.IJO_377_18","article-title":"Double-layer sign\" on spectral domain optical coherence tomography in pachychoroid spectrum disease","volume":"66","author":"Sheth","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib162","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/s41433-020-0886-0","article-title":"Pachydrusen: the epidemiology of pachydrusen and its relevance to progression of pachychoroid disease spectrum","volume":"34","author":"Sheth","year":"2020","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2024.08.003_bib163","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4103\/ijo.IJO_2703_20","article-title":"Changing trends in the use of anti-vascular endothelial growth factor (anti-VEGF) biosimilars: insights from the vitreoretinal society of india biosimilars of Anti-VEGF Survey","volume":"69","author":"Sheth","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib164","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.4103\/ijo.IJO_2985_21","article-title":"Updated guidelines for the management of polypoidal choroidal vasculopathy: recommendations from the indian polypoidal choroidal vasculopathy panel and the vitreoretinal society of India","volume":"70","author":"Sheth","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib165","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/archopht.121.10.1392","article-title":"Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics","volume":"121","author":"Sho","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"Suppl 1","key":"10.1016\/j.survophthal.2024.08.003_bib166","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1111\/j.1442-9071.1997.tb01745.x","article-title":"Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study","volume":"25","author":"Smith","year":"1997","journal-title":"Aust N Z J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib167","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0161-6420(00)00580-7","article-title":"Risk factors for age-related macular degeneration: pooled findings from three continents","volume":"108","author":"Smith","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib168","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96746-1","article-title":"De-novo multilayering in fibrovascular pigment epithelial detachment","volume":"11","author":"Soman","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.survophthal.2024.08.003_bib169","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s40123-022-00507-w","article-title":"Innovator versus biosimilar ranibizumab in polypoidal choroidal vasculopathy: real-world evidence","volume":"11","author":"Soman","year":"2022","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.survophthal.2024.08.003_bib170","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ajo.2008.10.005","article-title":"Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration","volume":"147","author":"Spaide","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.003","article-title":"Optical coherence tomography angiography","volume":"64","author":"Spaide","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.survophthal.2024.08.003_bib172","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","article-title":"Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group","volume":"127","author":"Spaide","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib173","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203337","article-title":"Cytokine profiles in the aqueous humor and serum of patients with dry and treated wet age-related macular degeneration","volume":"13","author":"Spindler","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.survophthal.2024.08.003_bib174","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.survophthal.2015.04.004","article-title":"Submacular hemorrhage in neovascular age-related macular degeneration: a synthesis of the literature","volume":"61","author":"Stanescu-Segall","year":"2016","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib175","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1167\/iovs.08-3225","article-title":"Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials","volume":"50","author":"Su\u00f1er","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2024.08.003_bib176","first-page":"498","article-title":"The role of new imaging methods in managing age-related macular degeneration","volume":"6","author":"Talks","year":"2017","journal-title":"Asia Pac J Ophthalmol (Philos)"},{"key":"10.1016\/j.survophthal.2024.08.003_bib177","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000446857","article-title":"Clinical application of multicolor imaging technology","volume":"236","author":"Tan","year":"2016","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.survophthal.2024.08.003_bib178","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.oret.2019.01.009","article-title":"Multicolor fundus imaging of polypoidal choroidal vasculopathy","volume":"3","author":"Tan","year":"2019","journal-title":"Ophthalmol Retin"},{"key":"10.1016\/j.survophthal.2024.08.003_bib179","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/ceo.13462","article-title":"Multicolour imaging for the detection of polypoidal choroidal vasculopathy and age-related macular degeneration","volume":"47","author":"Tan","year":"2019","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib180","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011504","article-title":"How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review","volume":"6","author":"Taylor","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.survophthal.2024.08.003_bib181","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.mcna.2021.01.003","article-title":"Age-related macular degeneration","volume":"105","author":"Thomas","year":"2021","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.survophthal.2024.08.003_bib182","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ajo.2005.10.012","article-title":"Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization","volume":"141","author":"Tong","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib183","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.survophthal.2017.01.008","article-title":"Retinal angiomatous proliferation","volume":"62","author":"Tsai","year":"2017","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib184","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.ophtha.2013.06.010","article-title":"Ranibizumab in myopic choroidal neovascularization: the 12-month results from the REPAIR study","volume":"120","author":"Tufail","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib185","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archopht.118.3.344","article-title":"Subretinal surgery for choroidal neovascularization in patients with high myopia","volume":"118","author":"Uemura","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib186","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ophtha.2007.04.023","article-title":"Autofluorescence imaging in age-related macular degeneration complicated by choroidal neovascularization: a prospective study","volume":"115","author":"Vaclavik","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib187","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.ophtha.2015.03.012","article-title":"Long-term results of full macular translocation for choroidal neovascularization in age-related macular degeneration","volume":"122","author":"van Romunde","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib188","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1001\/archopht.1996.01100140393005","article-title":"Age-related macular degeneration and smoking. The Rotterdam Study","volume":"114","author":"Vingerling","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib189","first-page":"478","article-title":"Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope","volume":"38","author":"von R\u00fcckmann","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2024.08.003_bib190","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0161-6420(01)01024-7","article-title":"Prevalence and progression of myopic retinopathy in an older population","volume":"109","author":"Vongphanit","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib191","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1167\/tvst.10.2.33","article-title":"Color fundus autofluorescence to determine activity of macular neovascularization in age-related macular degeneration","volume":"10","author":"Vujosevic","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib192","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1167\/iovs.15-18955","article-title":"Evaluating polypoidal choroidal vasculopathy with optical coherence tomography angiography","volume":"57","author":"Wang","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2024.08.003_bib193","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12886-019-1163-5","article-title":"Diagnostic accuracy of optical coherence tomography angiography for choroidal neovascularization: a systematic review and meta-analysis","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib194","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S0161-6420(00)00218-9","article-title":"A comparison of stereoscopic fluorescein angiography with indocyanine green videoangiography in age-related macular degeneration","volume":"107","author":"Watzke","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib195","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.ophtha.2016.04.021","article-title":"The prevalence of myopic choroidal neovascularization in the United States: analysis of the IRIS(\u00ae) data registry and NHANES","volume":"123","author":"Willis","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib196","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.ophtha.2015.05.042","article-title":"Comparison of age-related macular degeneration treatments trials research group. subretinal hyperreflective material in the comparison of age-related macular degeneration treatments trials","volume":"122","author":"Willoughby","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib197","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3928\/0191-3913-19880101-07","article-title":"Choroidal neovascularization in children: report of five cases and literature review","volume":"25","author":"Wilson","year":"1988","journal-title":"J Pedia Ophthalmol Strabismus"},{"key":"10.1016\/j.survophthal.2024.08.003_bib198","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ophtha.2013.10.023","article-title":"RADIANCE Study Group. RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia","volume":"121","author":"Wolf","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib199","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ajo.2013.08.010","article-title":"Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review","volume":"157","author":"Wong","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib200","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ajo.2019.02.027","article-title":"PLANET Investigators. Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy: two-year results of the aflibercept in polypoidal choroidal vasculopathy study","volume":"204","author":"Wong","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib201","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132771","article-title":"Analysis of genetic and environmental risk factors and their interactions in korean patients with age-related macular degeneration","volume":"10","author":"Woo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.survophthal.2024.08.003_bib202","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s00417-020-04869-4","article-title":"The prognostic value of total macular external limiting membrane and ellipsoid zone damage for clinical outcome in treatment-resistant neovascular age-related macular degeneration","volume":"258","author":"Woronkowicz","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.08.003_bib203","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.ophtha.2013.11.031","article-title":"The neovascular age-related macular degeneration database: multicenter study of 92\u2009976 ranibizumab injections: report 1: visual acuity","volume":"121","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.08.003_bib204","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/IAE.0000000000000086","article-title":"Subfoveal choroidal thickness in retinal angiomatous proliferation","volume":"34","author":"Yamazaki","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.08.003_bib205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132565","article-title":"Cross sectional and longitudinal associations between cardiovascular risk factors and age related macular degeneration in the EPIC-Norfolk eye study","volume":"10","author":"Yip","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.survophthal.2024.08.003_bib206","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bjophthalmol-2020-316820","article-title":"Geographic distributions of age-related macular degeneration incidence: a systematic review and meta-analysis","volume":"105","author":"Zhou","year":"2021","journal-title":"Br J Ophthalmol"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003962572400095X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003962572400095X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T13:29:52Z","timestamp":1747488592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003962572400095X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":206,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S003962572400095X"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2024.08.003","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macular neovascularization","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2024.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}